Good Morning,

Our lab just changed their instrumentation and started using the Ortho VITROS® XT 7600. The reference range for Vancomycin changed from 10-20 to 5-10 and we were told we can not modify it. Does anyone else's lab use this instrumentation and how have you been able to integrate this change clinically. Were you successful in changing the reference range?

Thank you!

Natalie Zilban
Medication Safety and Pharmacy Officer
Memorial Healthcare System

Hello!

Looking to resurface these medication administration topics...
Curious for each:

1) Labeling lines
- is this a requirement / spelled out in policy?
- are nurses compliant?
- do you use colorful stickers (a different color for each drug)?
- do you provide printed labels or are they handwritten?
- where are stickers placed?
- any higher leverage strategies in place to increase compliance?

Greetings!
I didn't see anything recently on this topic - But wondered what other organizations were doing with diluted insulin for their littlest patients.

Trying to figure out the new EUA for Remdesivir for peds. More specifically the fact that EUA seems to addressthe following 3 out of 4 groups in terms of dosing:
1. > 12 yo and >40 kG - FDA approved
2. < 12 yo and > 40 kG
3. < 12 yo and < 40 kG
What do we do for 12-18 yo pediatric patient who weighs < 40 kG?

Our outpatient oncology team has noticed an increased rate of cutaneous reactions to docetaxel not related to a specific manufacturer or lot number, some requiring ED transfer or other intervention/escalation of care.

The package insert includes a warning regarding cutaneous reactions, but we were wondering if anyone else is experiencing a similar trend. We have assessed our docetaxel utilization to see if it might be related to an increased utilization over the past few weeks, but our utilization has actually decreased.

Thank you!

Our site has had requests to add several new insulins to formulary for use in pediatrics. There is concern for look-alike/sound-alike storage and dispensing errors by adding new formulations.

Our site was requested to add Fiasp (insulin aspart), Lyumjev (insulin lispro), Humalog U-200 (insulin lispro 200 unit/mL), and diluted Novolog (insulin aspart 10 unit/mL).

Can any sites share if they have utilized any effective strategies to minimize this risk? A few examples are noted below but would appreciate if sites can share any helpful practices.

For those of you who also have retail pharmacies in your scope, I am interested to learn what your retail pharmacists use to visually verify the contents of a prescription. CVS, for example, has a patented visual verification pharmacy tray. This is great design; it offers a magnifying panel and deep tray to empty the contents of the prescription bottle for visual verification. Unfortunately, we are not easily identifying a company that offers this for us to purchase for use in our retail pharmacies. What equipment has worked well in your retail pharmacies?

Hi everyone,
I'm wondering if any of you have done/are aware of a detailed review on the PD of crushed nifedipine XL.

Hey all

Though the shortage has resolved, when Alteplase was on national shortage, did any of your institutions create any alterative protocols with other products, like Tenectaplase?

Thanks
Jameika Stuckey

We are in the process of upgrading our Anesthesia infusion pumps and was asked to get a survey of how many hospitals use:
1. Anesthesia smart pumps with drug libraries vs. 2. Anesthesia pumps without drug libraries
Would you please indicate 1 or 2 for your hospital?

Thanks,
Emil N Sidawy, PharmD
Adventist HealthCare